Position in LNTH
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$47,094,030
+$294,580 QoQ
Shares Held
424,500
-31.2% QoQ
Ownership
0.650%
of shares outstanding
% of Portfolio
4.52%
of 13F equity value
Holder Rank
#39
of 466 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Polaris Capital Management, LLC holds $79,265,107 across 5 Drug Manufacturers - Specialty & Generic names. LNTH ranks #1 (59.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
This page
|
424,500 | $47,094,030 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
53,450 | $28,960,813 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
|
15,600 | $1,291,368 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
22,500 | $1,046,475 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
43,232 | $872,421 |
All Filings in LNTH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,094,030 | 424,500 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $46,799,450 | 617,000 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $35,803,900 | 538,000 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $32,687,117 | 637,300 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||